DoW Pancreatic Cancer Research Program, Translational Research Partnership Award

The DoW Pancreatic Cancer Research Program, Translational Research Partnership Award, supports partnerships between clinicians, population scientists, applied scientists, and/or basic scientists to accelerate the movement of promising ideas in pancreatic cancer toward clinical applications. The partnership must include at least one member with expertise in pancreatic cancer research or pancreatic cancer patient care. Key aspects of this opportunity include: • The award mechanism requires preliminary data to support the feasibility of the research hypothesis(es) and research approaches. • Applications can support retrospective tissue analysis, correlative studies, and pilot clinical trials, but this mechanism does not allow large-scale clinical trials. • The Translational Research Partnership Award requires two Principal Investigators (PIs), referred to as the Initiating PI and the Partnering PI. • The estimated funding for this opportunity is $6,600,000, and the award ceiling is not specified.